MRSA Treatment Plan
Bacterial Infections
Viral Infections
Ultimate Supplements
Additional Supplements
Books & Resources
About Us


MRSA Information (also see essential oils)
06/02/2010
Whole Body Vibration (WBR) Introduction
02/24/2010
Pounds & Inches - Summary of Clinical Study
02/24/2010
Weight Loss Summary
02/24/2010
Additional Supplements
02/24/2010
Sambucol Against Viral Infections and Influenza
02/24/2010
Sambucol (From the Company)
02/24/2010
General Virus and Flu Explanation
02/24/2010
Sambucol Clinical Safety
02/24/2010
General Explanation of Antioxidants and Flavonoids
02/24/2010
Bird Flu (See Sambucol)
02/24/2010
Sambucol Clinical References
02/24/2010
Sambucol Clinical Effect on Herpes and HIV
02/24/2010
Sambucol Active Constituents and Mechanisms
02/24/2010
Monolaurin Anti-Bacteria & Staph Effects
02/24/2010
Irvingia
02/24/2010
Herxheimer Reaction
02/24/2010
Cellulitis
02/24/2010
Why Essential Oils Heal and Drugs Don't
02/24/2010
A Short History of Essential Oils
02/24/2010

 

 

 


Topic Tree | Search Information | Printer Friendly Page | Print

Sambucol Clinical Effect on Herpes and HIV

 
 
(Alternative Medicine Review, March 2005)

Herpes simplex
 
(Most references to herpes are based on the references here.  The results are promising but more clinical trials would be welcome.  The principle of prevention of virus reproduction prevention also applies - but remember that sambucol appears to only be effective on viruses outside the cells.  Virses resident within cells are not affected.)
 
Mumcuoglu et al examined the effects of Sambucol against HSV-1 in human diploid fibro-blasts. Four strains of HSV-1 were utilized--a reference strain, two acyclovir-resistant strains, and a strain isolated from a patient.
 
Viral replication was completely inhibited in all four strains, whether the cells were pre-incubated with the extract, simultaneously incubated with extract, or the extract was added 30 minutes after viral adsorption to cells.
 
The complete inhibition of four strains of HSV-1 in vitro by elderberry extract warrants further clinical trials in humans. (15) A formula of Sambucus nigra (flower extract) in combination with Hypericum perforatum and Saponaria officinalis was also found to inhibit the replication of HSV-1 in vitro. (22)
 

HIV
 
Sambucol was studied for the potential to inhibit the infectivity of HIV isolates in CD4+ cell lines, peripheral blood lymphocytes, and laboratory HIV strains. The elderberry extract at two different dilutions was pre-incubated with HIV virus prior to addition of the cells.
 
A significant reduction was observed in the infectivity of all HIV strains. In patient isolates treated with the extract, no HIV antigen was detected at either five or nine days post-incubation. (14)
 
Anecdotal evidence (six case studies) reports a combination of elderberry extract and a thymus extract resulted in a reduction in viral load in people with HIV. (23)
 

Conditions Associated with Oxidative Stress
 
Numerous disease states are characterized by oxidative stress, including cardiovascular disease, cancer, neurodegenerative disease, peripheral vascular disease, autoimmune diseases, and multiple sclerosis. The ability of elderberry extract to provide antioxidant protection via inhibition of LDL-oxidation and scavenging of free radicals makes it a potentially valuable tool in the treatment of disease resulting from oxidative stress. (19)
Elderberry's ability to incorporate into endothelial cells and potentially improve endothelial function may also indicate a role in prevention of vascular disease of various kinds.(21)
 

Effect on Blood Lipids
 
A randomized, placebo-controlled study of 34 healthy subjects examined the effectiveness of low-dose, powdered elderberry juice (10% anthocyanins) versus placebo on lipid parameters. Elderberry was dosed at 400 mg capsuled powder (equal to 5 mL elderberry juice) three times daily for two weeks; patients were instructed to follow a diet containing 35-percent fat.
 
Serum was obtained at baseline and at the end of the two-week period. Analysis of results showed a slight, but statistically insignificant, decrease at two weeks in all lipid parameters of the low-dose elderberry extract group compared to baseline.
 
Total cholesterol was 199 mg/dL at baseline versus 190 mg/dL at the end of the two-week period. Slight reductions were also reported in triglycerides, and HDL- and LDL-cholesterol. (24)
 
Although improvements in lipid values were statistically insignificant, the dosage of elderberry extract was low and it is possible higher dosages might produce a more significant benefit. In addition, using subjects with normal lipid levels may not be as likely to produce significant results since the lipids are already within the normal range. Further study on patients with elevated lipid levels is warranted.
 


   
While we make extensive effort to provide information and opinions from sources believed to be accurate, no guarantee can be made of that accuracy.  The information and publications provided within and by this website are meant only to help educate the reader and is in no way intended to be providing medical advice.  It is not intended to replace a physician's care or prescribed medication.  Readers and customers acknowledge this and that standard medical advice is that medical advice should always be sought from a qualified healthcare professional before beginning the use of any treatment.  Persons taking pharmaceutical medications and those with medical conditions should consult with a healthcare professional before using any treatment and products. The information provided by this website and these statements have not been evaluated by the Food And Drug Administration.  Any information and products are not intended to diagnose, treat, cure or prevent any disease.

Other Resources